| Net Cash Provided by (Used in) Operating Activities |
$905,739 |
USD |
-470% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$568,949 |
USD |
-204% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
11,593,402 |
shares |
36% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$534,406 |
USD |
-86% |
Q3 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$4,092 |
USD |
-96% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$10,102,099 |
USD |
16% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$10,105,500 |
USD |
13% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability |
$767,450 |
USD |
-16% |
Q2 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$1,002,011 |
USD |
-18% |
Q2 2024 |
Q3 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$7,186,210 |
USD |
15% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
$54,180,589 |
USD |
5.7% |
Q3 2025 |
FY 2025 |
| Amortization of Intangible Assets |
$196,602 |
USD |
0% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$2,873,750 |
USD |
4535% |
Q4 2024 |
Q1 2025 |